SEARCH

SEARCH BY CITATION

References

  • 1
    Present DH, Korelitz BI, Wisch N, Glass JL, Sachar DB, Pasternack BS Treatment of Crohn's disease with 6-mercaptopurine. A long term randomized double blind study. N Eng J Med 1980; 11: 9817.
  • 2
    O'Brian JJ, Bayless TM, Bayless JA Use of azathioprine or 6-mercaptopurine in the treatment of Crohn's disease. Gastroenterology 1991; 11: 3946.
  • 3
    Hodgson HJ Cyclosporin in inflammatory bowel disease. Aliment Pharmacol Ther 1991; 11: 34350.
  • 4
    Klippel JH & Decker JL Methotrexate in rheumatoid arthritis. N Eng J Med 1985; 11: 8534.
  • 5
    Weinblatt ME, Coblyn JS, Fox DA, et al. Efficacy of low-dose methotrexate in rheumatoid arthritis. N Eng J Med 1985; 11: 81822.
  • 6
    Willkens RF, Williams HJ, Ward JR, et al. Randomized, double blind, placebo controlled trial of low-dose pulse methotrexate in psoriatic arthritis. Arthritis Rheum 1984; 11: 37681.
  • 7
    Kozarek RA, Patterson DJ, Gelfand MD, Botoman VA, Ball TJ, Wilske KR Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease. Ann Intern Med 1989; 11: 3536.
  • 8
    Chmiot-Prieur C, Lemann  M, Mesnard B, et al. Treatment of refractory Crohn's disease with methotrexate. Gastroenterology 1993; 11: A680 (Abstract).
  • 9
    Feagan BG, Rochon J, Fedorak RN, et al. Methotrexate for the treatment of Crohn's disease. N Eng J Med 1995; 11: 2927.
  • 10
    Baron TH, Truss CD, Elson CO Low-dose oral methotrexate in refractory inflammatory bowel disease. Dig Dis Sci 1993; 11: 18516.
  • 11
    Pesce MA & Bodourian DH Evaluation of fluorescence polarization immunoassay procedure for quantitation of methotrexate. Ther Drug Monit 1986; 11: 11521.
  • 12
    Sinnett MJ, Groff GD, Raddatz DA, Franck WA, Bertino JS Methotrexate pharmacokinetics in patients with rheumatoid arthritis. J Rheumatol 1989; 11: 7458.
  • 13
    Furst DE Clinical pharmacology of very low dose methotrexate for use in rheumatoid arthritis. J Rheumatol 1985; 11 (Suppl. 12): 114.
  • 14
    Jolivet J, Cowan KH, Curt GA, Clendeninn NJ, Chabner BA The pharmacology and clinical use of methotrexate. N Eng J Med 1983; 11: 1094104.
  • 15
    Balis FM, Savitch JL, Bleyer WA Pharmacokinetics of oral methotrexate in children. Cancer Res 1983; 11: 23425.
  • 16
    Wan SH, Huffman DH, Azarnoff DC, Stephens R, Hoogstraten B Effect of route of administration and effusion on methotrexate pharmacokinetics. Cancer Res 1974; 11: 348791.
  • 17
    Pinkerton CR, Glasgow JFT, Welchman SG, Bridges JM Can food influence the absorption of methotrexate in children with acute lymphoblastic leukemia? Lancet 1980; i: 9446.
  • 18
    Oguey D, Kolliker F, Gerber NJ, Reichen J Effect of food on the bioavailability of low-dose methotrexate in patients with rheumatoid arthritis. Arthritis Rheum 1992; 11: 6114.
  • 19
    Kozloski GD, De Vito JM, Kisicki JC, Johnson JB The effect of food on the absorption of methotrexate sodium tablets in healthy volunteers. Arthritis Rheum 1992; 11: 7614.
  • 20
    Cohen MN, Creaven PF, Fossieck BE, Johnson AV, Williams CL Effect of oral prophylactic broad spectrum nonabsorbable antibiotics on the gastrointestinal absorption of nutrients and methotrexate in small cell bronchogenic carcinoma patients. Cancer 1976; 11: 15569.
  • 21
    Shen DD & Azranoff DL Clinical pharmacokinetics of methotrexate. Clin Pharmacokinet 1978; 11: 113.
  • 22
    Charland SL, Barlett D, Torosian NH Effect of protein-calorie malnutrition on methotrexate pharmacokinetics. J Parenter Enteral Nutr 1994; 11: 459.